Leisa Johnson
Impact in
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Cancer Research top 2%
Papers in
-
- Viral Infectious Diseases and Gene Expression in Insects 3
- PI3K/AKT/mTOR signaling in cancer 3
- Oncology 10
- Cancer-related Molecular Pathways 4
- Cancer Cells and Metastasis 4
- CAR-T cell therapy research 3
- Co-authors
- Tyler Jacks (5 shared papers)Doron C. Greenbaum (2 shared papers)Kim L. Mercer (2 shared papers)Roderick T. Bronson (2 shared papers)David A. Tuveson (3 shared papers)Denise Crowley (1 shared paper)Kevin G. Leong (2 shared papers)Wei‐Qiang Gao (2 shared papers)
- Journals
- Cancer Research (4 papers)Cancer Cell (3 papers)Clinical Cancer Research (2 papers)Nature (2 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesFranceSingapore
In The Last Decade
Leisa Johnson
24 papers receiving 4.3k citations
Leisa Johnson's Hit Papers
Peers
Comparison fields: 5 of 106
- Oncology 1.8k
- Cancer Research 650
- Genetics 1.2k
- Biotechnology 358
- Molecular Biology 2.8k
Countries citing papers authored by Leisa Johnson
This map shows the geographic impact of Leisa Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leisa Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leisa Johnson more than expected).
Fields of papers citing papers by Leisa Johnson
This network shows the impact of papers produced by Leisa Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leisa Johnson. The network helps show where Leisa Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Leisa Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Somatic activation of the K-ras oncogene causes early onset lung cancer in mice Hit paper breakdown → | 2001 | 910 |
| 2 | 2000 | 488 | |
| 3 | 1997 | 449 | |
| 4 | 2008 | 344 | |
| 5 | 2008 | 331 | |
| 6 | 2004 | 295 | |
| 7 | 2011 | 287 | |
| 8 | 2001 | 245 | |
| 9 | 2004 | 207 | |
| 10 | 2010 | 176 | |
| 11 | 2002 | 151 | |
| 12 | 2020 | 104 | |
| 13 | 2014 | 98 | |
| 14 | 2012 | 91 | |
| 15 | 2001 | 81 | |
| 16 | 2006 | 60 | |
| 17 | 2015 | 44 | |
| 18 | A prodrug strategy using ONYX-015-based replicating adenoviruses to deliver rabbit carboxylesterase to tumor cells for conversion of CPT-11 to SN-38. | 2003 | 27 |
| 19 | 2004 | 21 | |
| 20 | 2015 | 11 |
About Leisa Johnson
Leisa Johnson is a scholar working on Molecular Biology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Cell Biology, having authored 24 papers that have together received 4.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), Cancer-related Molecular Pathways (4 papers), Cancer Cells and Metastasis (4 papers), Microtubule and mitosis dynamics (3 papers), CAR-T cell therapy research (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (650 citations), Genetics (1.2k citations), Biotechnology (358 citations) and Molecular Biology (2.8k citations). Leisa Johnson has collaborated with scholars based in United States, France and Singapore. Frequent co-authors include Tyler Jacks, Doron C. Greenbaum, Kim L. Mercer, Roderick T. Bronson, David A. Tuveson, Denise Crowley, Kevin G. Leong, Wei‐Qiang Gao, Bu-Er Wang and Terry Hermiston. Their work appears in journals such as Cancer Research, Cancer Cell, Clinical Cancer Research, Nature and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.